ERCC5 and coronary artery disorder: On the whole, as suggested from the mentioned results, the expression of diagnostic markers ERCC5, HES6 and RORA (AUC > 0.8) is correlated with the progression of CAD and they may be used as biomarkers to assess the pathogenesis of CAD and validate the effectiveness of CAD treatment.